19 October 2018 - Deborah Wilkes
Archived
Johnson & Johnson's (J&J's) Consumer division stepped up its performance in the third quarter of 2018, recording "above-market growth" of 4.9% on an operational basis. Sales at the division's OTC business increased by 6.8% compared to the same period a year earlier.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.